| pubmed-article:1495819 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1495819 | lifeskim:mentions | umls-concept:C0149931 | lld:lifeskim |
| pubmed-article:1495819 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:1495819 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:1495819 | pubmed:dateCreated | 1992-9-8 | lld:pubmed |
| pubmed-article:1495819 | pubmed:abstractText | Positron emission tomography (PET) is a brain imaging technique that allows in vivo studies of numerous physiological parameters. There have been few PET studies in migraine patients. Cerebral blood flow changes with no variations in brain oxygen consumption have been reported in patients with prolonged neurologic manifestations during migraine attacks. Parenteral administration of reserpine during migraine headache has been followed by a fall in the overall cerebral uptake of glucose. The small sample sizes and a number of methodologic problems complicate the interpretation of these results. Recent technical advances and the development of new PET tracers can be expected to provide further insight into the pathophysiology of migraine. Today cerebral cortex 5 HT2 serotonin receptors can be studied in migraine patients with PET. | lld:pubmed |
| pubmed-article:1495819 | pubmed:language | fre | lld:pubmed |
| pubmed-article:1495819 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1495819 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1495819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1495819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1495819 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1495819 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:1495819 | pubmed:issn | 0369-8114 | lld:pubmed |
| pubmed-article:1495819 | pubmed:author | pubmed-author:ChabriatHH | lld:pubmed |
| pubmed-article:1495819 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1495819 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:1495819 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1495819 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1495819 | pubmed:pagination | 344-8 | lld:pubmed |
| pubmed-article:1495819 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:1495819 | pubmed:meshHeading | pubmed-meshheading:1495819-... | lld:pubmed |
| pubmed-article:1495819 | pubmed:meshHeading | pubmed-meshheading:1495819-... | lld:pubmed |
| pubmed-article:1495819 | pubmed:meshHeading | pubmed-meshheading:1495819-... | lld:pubmed |
| pubmed-article:1495819 | pubmed:meshHeading | pubmed-meshheading:1495819-... | lld:pubmed |
| pubmed-article:1495819 | pubmed:meshHeading | pubmed-meshheading:1495819-... | lld:pubmed |
| pubmed-article:1495819 | pubmed:meshHeading | pubmed-meshheading:1495819-... | lld:pubmed |
| pubmed-article:1495819 | pubmed:meshHeading | pubmed-meshheading:1495819-... | lld:pubmed |
| pubmed-article:1495819 | pubmed:meshHeading | pubmed-meshheading:1495819-... | lld:pubmed |
| pubmed-article:1495819 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1495819 | pubmed:articleTitle | [Positron emission tomography and migraine]. | lld:pubmed |
| pubmed-article:1495819 | pubmed:affiliation | Service Hospitalier Frédéric Joliot, Orsay, France. | lld:pubmed |
| pubmed-article:1495819 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1495819 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:1495819 | pubmed:publicationType | Review | lld:pubmed |
